Neurodevelopmental and genetic determinants of exposure to adversity among youth at risk for mental illness.


Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
05 2020
Historique:
accepted: 10 10 2019
pubmed: 22 11 2019
medline: 18 9 2021
entrez: 22 11 2019
Statut: ppublish

Résumé

Attention-deficit/hyperactivity disorder (ADHD) and lower cognitive ability have been linked with increased likelihood of exposure to adversity. We hypothesized that these associations may be partly due to genetic factors. We calculated polygenic scores for ADHD and intelligence and assessed psychopathology and general cognitive ability in a sample of 297 youth aged 5-27 years enriched for offspring of parents with mood and psychotic disorders. We calculated an adversity score as a mean of 10 indicators, including socio-economic disadvantage, childhood maltreatment and bullying. We tested the effects of polygenic scores, externalizing symptoms and IQ on adversity scores using mixed-effects linear regression. Externalizing symptoms and general cognitive ability showed expected positive and negative relationships with adversity, respectively. Polygenic scores for intelligence were unrelated to adversity, but polygenic scores for ADHD were associated with adversity (β = 0.23, 95% CI 0.13 to 0.34, p < .0001). ADHD polygenic scores uniquely explained 4.0% of variance in adversity score. The relationship between polygenic scores for ADHD and adversity was independently significant among individuals with (β = 0.49, 95% CI 0.25 to 0.75, p < .0001) and without (β = 0.14, 95% CI 0.02 to 0.26, p = .022) ADHD. A genetic score indexing liability to ADHD was associated with exposure to adversity in early life. Previously observed associations between externalizing symptoms, lower cognitive ability and adversity may be partially attributed to genetic liability to ADHD.

Sections du résumé

BACKGROUND
Attention-deficit/hyperactivity disorder (ADHD) and lower cognitive ability have been linked with increased likelihood of exposure to adversity. We hypothesized that these associations may be partly due to genetic factors.
METHODS
We calculated polygenic scores for ADHD and intelligence and assessed psychopathology and general cognitive ability in a sample of 297 youth aged 5-27 years enriched for offspring of parents with mood and psychotic disorders. We calculated an adversity score as a mean of 10 indicators, including socio-economic disadvantage, childhood maltreatment and bullying. We tested the effects of polygenic scores, externalizing symptoms and IQ on adversity scores using mixed-effects linear regression.
RESULTS
Externalizing symptoms and general cognitive ability showed expected positive and negative relationships with adversity, respectively. Polygenic scores for intelligence were unrelated to adversity, but polygenic scores for ADHD were associated with adversity (β = 0.23, 95% CI 0.13 to 0.34, p < .0001). ADHD polygenic scores uniquely explained 4.0% of variance in adversity score. The relationship between polygenic scores for ADHD and adversity was independently significant among individuals with (β = 0.49, 95% CI 0.25 to 0.75, p < .0001) and without (β = 0.14, 95% CI 0.02 to 0.26, p = .022) ADHD.
CONCLUSIONS
A genetic score indexing liability to ADHD was associated with exposure to adversity in early life. Previously observed associations between externalizing symptoms, lower cognitive ability and adversity may be partially attributed to genetic liability to ADHD.

Identifiants

pubmed: 31749149
doi: 10.1111/jcpp.13159
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

536-544

Subventions

Organisme : CIHR
ID : 124976
Pays : Canada
Organisme : CIHR
ID : 142738
Pays : Canada
Organisme : CIHR
ID : 148394
Pays : Canada

Informations de copyright

© 2019 Association for Child and Adolescent Mental Health.

Références

Adler, N.E., Boyce, T., Chesney, M.A., Cohen, S., Folkman, S., Kahn, R.L., & Syme, S.L. (1994). Socioeconomic status and health. American Psychologist, 49, 15-24.
Agnew-Blais, J.C., & Danese, A. (2016). Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: A systematic review and meta-analysis. The Lancet Psychiatry, 3, 342-349.
Agnew-Blais, J.C., Polanczyk, G.V., Danese, A., Wertz, J., Moffitt, T.E., & Arseneault, L. (2016). Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry, 73, 713.
Agnew-Blais, J.C., Polanczyk, G.V., Danese, A., Wertz, J., Moffitt, T.E., & Arseneault, L. (2018). Young adult mental health and functional outcomes among individuals with remitted, persistent and late-onset ADHD. The British Journal of Psychiatry, 213, 526-534.
Bifulco, A., Brown, G.W., & Harris, T.O. (1994). Childhood Experience of Care and Abuse (CECA): A retrospective interview measure. Journal of Child Psychology and Psychiatry, 35, 1419-1435.
Brikell, I., Larsson, H., Lu, Y., Pettersson, E., Chen, Q., Kuja-Halkola, R., … & Martin, J. (2018). The contribution of common genetic risk variants for ADHD to a general factor of childhood psychopathology. Molecular Psychiatry. [Epub ahead of print]. https://doi.org/10.1038/s41380-018-0109-2
Dalsgaard, S., Østergaard, S.D., Leckman, J.F., Mortensen, P.B., & Pedersen, M.G. (2015). Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: A nationwide cohort study. The Lancet, 385, 2190-2196.
Danese, A., & McEwen, B.S. (2012). Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiology & Behavior, 106, 29-39.
Danese, A., Moffitt, T.E., Arseneault, L., Bleiberg, B.A., Dinardo, P.B., Gandelman, S.B., … & Caspi, A. (2017). The origins of cognitive deficits in victimized children: Implications for neuroscientists and clinicians. American Journal of Psychiatry, 174, 349-361.
Demontis, D., Walters, R.K., Martin, J., Mattheisen, M., Als, T.D., Agerbo, E., … & Neale, B.M. (2019). Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51, 63-75.
Euesden, J., Lewis, C.M., & O’Reilly, P.F. (2015). PRSice: Polygenic Risk Score software. Bioinformatics, 31, 1466-1468.
Finkelhor, D., Hamby, S.L., Ormrod, R., & Turner, H. (2005). The Juvenile Victimization Questionnaire: Reliability, validity, and national norms. Child Abuse & Neglect, 29, 383-412.
First, M.B. (2015). Structured Clinical Interview for the DSM (SCID). In R.L. Cautin, & S.O. Lilienfeld (Eds.), The encyclopedia of clinical psychology (pp. 1-6). Hoboken, NJ: John Wiley & Sons, Inc.
Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., … & Ryan, N. (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 980-988.
Larsson, H., Chang, Z., D’Onofrio, B.M., & Lichtenstein, P. (2014). The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan. Psychological Medicine, 44, 2223-2229.
Lindert, J., von Ehrenstein, O.S., Grashow, R., Gal, G., Braehler, E., & Weisskopf, M.G. (2014). Sexual and physical abuse in childhood is associated with depression and anxiety over the life course: Systematic review and meta-analysis. International Journal of Public Health, 59, 359-372.
Martin, J., Hamshere, M.L., Stergiakouli, E., O’Donovan, M.C., & Thapar, A. (2014). Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population. Biological Psychiatry, 76, 664-671.
Martin, J., Hamshere, M.L., Stergiakouli, E., O’Donovan, M.C., & Thapar, A. (2015). Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder. Journal of Child Psychology and Psychiatry, 56, 648-656.
Martin, J., Tilling, K., Hubbard, L., Stergiakouli, E., Thapar, A., Davey Smith, G., … & Zammit, S. (2016). Association of genetic risk for schizophrenia with nonparticipation over time in a population-based cohort study. American Journal of Epidemiology, 183, 1149-1158.
Meier, S.M., Pavlova, B., Dalsgaard, S., Nordentoft, M., Mors, O., Mortensen, P.B., & Uher, R. (2018). Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood. The British Journal of Psychiatry, 213, 555-560.
Mills, R., Alati, R., O’Callaghan, M., Najman, J.M., Williams, G.M., Bor, W., & Strathearn, L. (2011). Child abuse and neglect and cognitive function at 14 years of age: Findings from a birth cohort. Pediatrics, 127, 4-10.
Nanni, V., Uher, R., & Danese, A. (2012). Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: A meta-analysis. American Journal of Psychiatry, 169, 141-151.
Padmanabhan, J.L., Shah, J.L., Tandon, N., & Keshavan, M.S. (2017). The “polyenviromic risk score”: Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects. Schizophrenia Research, 181, 17-22.
Plomin, R., DeFries, J.C., & Loehlin, J.C. (1977). Genotype-environment interaction and correlation in the analysis of human behavior. Psychological Bulletin, 84, 309-322.
Radford, L., Corral, S., Bradley, C., & Fisher, H.L. (2013). The prevalence and impact of child maltreatment and other types of victimization in the UK: Findings from a population survey of caregivers, children and young people and young adults. Child Abuse & Neglect, 37, 801-813.
Savage, J.E., Jansen, P.R., Stringer, S., Watanabe, K., Bryois, J., de Leeuw, C.A., … & Posthuma, D. (2018). Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nature Genetics, 50, 912-919.
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421-427.
Schoeler, T., Choi, S.W., Dudbridge, F., Baldwin, J., Duncan, L., Cecil, C.M., … & Pingault, J.-B. (2019). Multi-polygenic score approach to identifying individual vulnerabilities associated with the risk of exposure to bullying. JAMA Psychiatry, 76, 730.
Sjöwall, D., Roth, L., Lindqvist, S., & Thorell, L.B. (2013). Multiple deficits in ADHD: Executive dysfunction, delay aversion, reaction time variability, and emotional deficits. Journal of Child Psychology and Psychiatry, 54, 619-627.
Stahl, E., Breen, G., Forstner, A., McQuillin, A., Ripke, S., Cichon, S., … & Sklar, P. (2019). Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics, 51, 793-803.
Stergiakouli, E., Martin, J., Hamshere, M.L., Heron, J., St Pourcain, B., Timpson, N.J., … & Davey Smith, G. (2017). Association between polygenic risk scores for attention-deficit hyperactivity disorder and educational and cognitive outcomes in the general population. International Journal of Epidemiology, 46, 421-428.
Stern, A., Agnew-Blais, J.C., Danese, A., Fisher, H.L., Jaffee, S.R., Matthews, T., … & Arseneault, L. (2018). Associations between abuse/neglect and ADHD from childhood to young adulthood: A prospective nationally-representative twin study. Child Abuse & Neglect, 81, 274-285.
Trotta, A., Di Forti, M., Mondelli, V., Dazzan, P., Pariante, C., David, A., … & Fisher, H.L. (2013). Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls. Schizophrenia Research, 150, 169-175.
Uher, R., Cumby, J., MacKenzie, L.E., Morash-Conway, J., Glover, J.M., Aylott, A., … & Alda, M. (2014). A familial risk enriched cohort as a platform for testing early interventions to prevent severe mental illness. BMC Psychiatry, 14, 344.
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., … & Bentall, R.P. (2012). Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies. Schizophrenia Bulletin, 38, 661-671.
Wechsler, D. (1999). Wechsler abbreviated scale of intelligence. San Antonio: Psychological Corporation.
Wray, N.R., Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E.M., Abdellaoui, A., … & Sullivan, P.F. (2018). Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nature Genetics, 50, 668-681.
Zwicker, A., Denovan-Wright, E.M., & Uher, R. (2018). Gene-environment interplay in the etiology of psychosis. Psychological Medicine, 48(12), 1925-1936.

Auteurs

Alyson Zwicker (A)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Pathology, Dalhousie University, Halifax, NS, Canada.

Lynn E MacKenzie (LE)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.

Vladislav Drobinin (V)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada.

Amina M Bagher (AM)

Department of Pharmacology and Toxicology, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.

Emily Howes Vallis (E)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Lukas Propper (L)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

Alexa Bagnell (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

Sabina Abidi (S)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

Barbara Pavlova (B)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Martin Alda (M)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Eileen M Denovan-Wright (EM)

Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.

Rudolf Uher (R)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Pathology, Dalhousie University, Halifax, NS, Canada.
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.
Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH